PASITHEA THERAPEUTICS CORP. Current Assets
PASITHEA THERAPEUTICS CORP. (KTTA) had Current Assets of $48.24 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $48.24M.
- 2026-03-31: Assets, Current $52.73M.
- 2025-12-31: Assets, Current $56.46M.
- 2025-09-30: Assets, Current $5.53M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $48.24M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $52.73M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $56.46M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $5.53M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $8.64M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $6.12M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $7.37M 10-K · filed 2026-03-30 |
| 2024-09-30 | $9.78M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $8.64M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $13.19M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $16.69M 10-K · filed 2025-03-24 |
| 2023-09-30 | $20.77M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $28.04M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $31.11M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $34.08M 10-K · filed 2024-03-29 |
| 2022-09-30 | $44.47M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $48.61M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $50.95M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $53.30M 10-K · filed 2023-03-30 |
| 2021-09-30 | $21.03M 10-Q · filed 2021-11-18 |
| 2020-12-31 | $247.96K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |